Dergiler / Selçuk Tıp Dergisi / 2020 / Cilt: 36 - Sayı: 2

The Effect of Direct Oral Anticoagulant Drugs on Platelet Indiceses and Their Relationship with Bleeding Events

Sayfa
123–128
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

All characteristics of those with and without hemorrhagic events were also similar of patients with non-valvular AF.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Atrial fibrillation is a common disorder and is an important cause of thromboembolic events.
📊
Temel Bulgular & Veri:Patients and Methods: 301 patients with atrial fibrillation who were using DOACs were included in the study.
💡
Sonuç & Katkı:All characteristics of those with and without hemorrhagic events were also similar of patients with non-valvular AF.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: Atrial fibrillation is a common disorder and is an important cause of thromboembolic events. Recently, direct oral anticoagulant drugs (DOACs) are being used to reduce the frequency of thromboembolic events among these patients. DOACs have several advantages over oral vitamin K antagonists, such as fixed dosage and fewer side effects. However, since the drugs and their affects cannot be monitored directly, difficulties are encountered in assessing drug efficacy and side effects. For this purpose, platelet indices and their relationship with DOACs may be utilized for the prediction of thromboembolic and hemorrhagic events. Patients and Methods: 301 patients with atrial fibrillation who were using DOACs were included in the study. Platelet indices such as platelet count, platelet distribution volume, plateletcrit, platelet-large cell ratio were evaluated at the first and sixth months. The effect of DOACs on these indices and relationships with bleeding events were investigated.Results: All groups were similar in regard to baseline platelet indices, except for lower P-LCR value among recipients of rivaroxaban. When post-treatment results were compared, all groups were found to have similar values in all parameters. However, time-bound comparisons revealed that apixaban and dabigatran significantly reduced P-LCR value after 6 months of use. Conclusion: This study showed that apixaban, rivoraxaban and dabigatran had no effect on platelet count, MPV, PDW, PCT values in whole blood count of patients with non-valvular AF. All characteristics of those with and without hemorrhagic events were also similar of patients with non-valvular AF.

🔖

Bu Makaleye Atıf Yap

AKSİT, E., AYDİN, F., YİLDİRİM, O. T., DAGTEKİN, E., AYDİN, A. H. (2020). The Effect of Direct Oral Anticoagulant Drugs on Platelet Indiceses and Their Relationship with Bleeding Events. Selçuk Tıp Dergisi, Cilt: 36 - Sayı: 2, 123–128. https://ajindex.com/articles/319617

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Camm AJ, Kirchhof P, Lip GY, et al. The european heart rhythm association, and the european association for cardio-thoracic surgery. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (ESC). Eur Heart J 2010;31:2369-429
  2. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fi brillation. N Engl J Med 2003;349:1019-26
  3. Hart RG, Pearce LA. Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67
  4. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials. Lancet 2014;383:955-62
  5. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Steering committee and investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51
  6. Granger CB, Alexander JH, McMurray JJ, et al. Aristotle committees and investigators. Apixaban versus warfarin in patients with Atrial fibrillation. N Engl J Med 2011;365:981-92
  7. Patel MR, Mahaffrey KW, Garg J, et al. Rocket af investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91
  8. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomized trials. Lancet 2014;383955-62
  9. Eikelboom J, Merli G. Bleeding with direct oral anticoagulants vs warfarin: Clinical experience, Am J Med 2016;129:33-40
  10. Ates I, Bulut M, Ozkayar N, et al. Association between high platelet indices and proteinuria in patients with hypertension. Ann Lab Med 2015;35:630-4
  11. Ates H, Ates I, Kundi H, et al. Diagnostic validity of hematologic parameters in evaluation of massive pulmonary embolism. J Clin Lab Anal 2017;31(5)
  12. Senel T, Ates I, Demir BF, et al. The diagnostic valueof platelet indices in the gastrointestinal system bleeding and its place in predicting prognosis. Am J Emerg Med 2018;3
  13. Tanoglu A, Kara M, Yazgan Y, et al. Artmış ortalama trombosit hacmi üst gastrointestinal sistem kanamalarında yatış süresi ve transfüzyon ihtiyacı ile ilişkilidir. Gulhane Medical Journal 2015;57
  14. Decousus H, Tapson VF, Bergmann JF, et a